2
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Immunological and pathological observations with Candida albicans-infected animals

, , &
Pages 185-194 | Received 26 Mar 1981, Accepted 25 Jan 1983, Published online: 09 Jul 2009
 

Abstract

Mice and rabbits immunized intraperitoneally or intradermally with an ethanol-killed crude Candida albicans antigen and non-immunized controls were infected intravenously with C. albicans. The mortality rates clearly demonstrated immune protection, although the proportion of dead cells in the Candida immunization dose was inversely related to the degree of protection. Histopathological observations demonstrated distinct differences in the morphology of the fungal cells as well as in the host tissue reaction between the immunized and the non-immunized animals.

Zusammenfassung

Nicht-immunisierte und intraperitoneal oder intradermal mit äthanol-inaktiviertem Candida albicans-Antigen immunisierte Mäuse und Kaninchen wurden intravenös mit Candida albicans infiziert. Die Sterberaten belegen deutlich den protektiven Wert der Immunisierung, obgleich der Anteil toter Zellen in der Candida-Infektionsdosis die Schutzwirkung mindert. Die histopathologischen Befunde ergeben deutliche Unterschiede sowohl in der Morphologie der Pilzzellen als auch in der Wirtsgewebsreaktion zwischen den immunisierten und den nicht-immunisierten Tieren.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.